epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Basaglar
    insulin glargine
  • remove Ilaris
    canakinumab
  • remove Jardiance
    empagliflozin
  • remove Xywav
    calcium oxybate/ magnesium oxybate/ potassium oxybate/ sodium oxybate

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx
Smiley face Smiley face Basaglar (insulin glargine) + Jardiance (empagliflozin)

Monitor/Modify Tx

insulin + empagliflozin

monitor glucose; consider dose adjustment of one or both drugs: combo may incr. risk of hypoglycemia (additive effects)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information